TE_92
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | THE1A |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | LINC02606, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 5.84 |
| Counts of samples | TCGA_tumor:56; TCGA_normal:0; GTEx:10 |
| TSS | chr1(-):9451217 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_92.1 | LINC02606 | Chimeric | Non-coding | Non-coding | chr1(-):9427361,9427381,9440459,9440517,9441809,9441930,9444232,9444437,9444943,9449414,9450066,9450250,9450347,9450416,9451140,9451218 |
| teRNA_92.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449394,9449414,9450066,9450250,9450347,9450416,9451140,9451218 |
| teRNA_92.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449331,9449351,9450066,9450250,9450347,9450416,9451140,9451218 |
| teRNA_92.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):9445021,9445041,9446763,9446868,9450066,9450250,9450347,9450416,9451140,9451218 |
| teRNA_92.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449394,9449414,9450066,9450250,9451140,9451218 |
| teRNA_92.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449331,9449351,9450066,9450250,9451140,9451218 |
| teRNA_92.7 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449774,9449794,9450066,9450250,9451140,9451218 |
| teRNA_92.8 | - | Intergenic | Non-coding | Non-coding | chr1(-):9440497,9440517,9441809,9441930,9450066,9450250,9451140,9451218 |
| teRNA_92.9 | - | Intergenic | Non-coding | Non-coding | chr1(-):9446848,9446868,9450066,9450250,9451140,9451218 |
| teRNA_92.10 | - | Intergenic | Non-coding | Non-coding | chr1(-):9428373,9428393,9450066,9450250,9451140,9451218 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
